Epidemiology of Non-syndromic Dominant Deafness
SURDOM
Genetic Epidemiology of Non-syndromic Dominant Deafness
1 other identifier
observational
183
1 country
1
Brief Summary
Hearing impairment is a common disorder that affects at least 7% of individuals in our countries. Even the causes of hearing impairment are numerous, genetic causes represent the main factor of sensorineural deafness. Among hereditary non-syndromic deafness autosomal-dominant inheritance is observed in about 10-20% of the cases. These forms of deafness are usually post-lingual and progressive. To date more than 41 chromosomal localisation and 21 genes associated to non syndromic dominant deafness have been described. It represents an extreme genetic heterogeneity making difficult the studies of these forms of hearing impairment. But, genetic diagnostic testing is crucial in these cases. Indeed, therapeutic research are in the way to prevent the progression of the disorder. The aim of this work is to establish the prevalence of the different genes involved in these forms of deafness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 29, 2010
CompletedFirst Posted
Study publicly available on registry
June 24, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedAugust 7, 2013
August 1, 2013
3 years
March 29, 2010
August 6, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The identification of a deleterious mutation of a gene coding a protein present in the cochlea
1 day
Secondary Outcomes (1)
The phenotype genotype relationships after identification of the causative gene and mutation
1 day
Study Arms (2)
1
Patient presenting familial dominant non syndromic hearing loss starting between 4 and 40 years old, over 2 generations
2
Healthy volunteer from the same families
Interventions
Eligibility Criteria
families with non syndromic dominant hearing impairment followed by the clinical investigators
You may qualify if:
- Age \> 4 years.
- Patient presenting familial dominant non syndromic hearing loss starting between 4 and 40 years old, over 2 generations
- Healthy volunteer from the same families
- Clinical and paraclinical assessment (genetic and ophthalmologic examination, audiometric tests, inner ear CT scan)
- Affiliated to the national health insurance benefit
- Signature of informed consent form
You may not qualify if:
- hearing loss resulting from an extrinsic reason or an associated syndrome
- Defective or insufficient samples
- No or insufficient clinical and biological description
- No informed consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Armand-Trousseau, Service d'ORL pédiatrique et de Chirurgie Maxillo Faciale
Paris, 75012, France
Biospecimen
Peripheral whole blood
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Françoise Denoyelle, MD, PhD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2010
First Posted
June 24, 2010
Study Start
April 1, 2009
Primary Completion
April 1, 2012
Study Completion
April 1, 2012
Last Updated
August 7, 2013
Record last verified: 2013-08